Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. 2001

J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
Institute of Digestive Diseases, University Hospital Marqués de Valdecilla, School of Medicine, Santander, Spain. javiercrespo@teleline.es

The main objective of this study was to analyze the pathogenic role of the tumor necrosis factor alpha (TNF-alpha) system in the development of nonalcoholic steatohepatitis (NASH). Fifty-two obese patients were studied. We investigated: (1) the expression of mRNA of TNF-alpha and their p55 and p75-receptors by quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) in hepatic and adipose tissues; and (2) the relationship between TNF-alpha, p55, and p75 and the severity of NASH. Obese patients without NASH were the control group. A remarkable increase in the expression of mRNA of TNF-alpha was found in patients with NASH in hepatic tissue (0.65 +/- 0.54) and in peripheral fat (0.43 +/- 0.45); in the control samples, the mRNA expression was 0.28 +/- 0.32, P <.007, and 0.26 +/- 0.22, P <.018, respectively. Furthermore, we found a significant increase in the mRNA levels of p55 receptor (2.42 +/- 1.81 vs. 1.56 +/- 1.17; P <.05); however, the mRNA expression of the p75 receptor was similar in both patients. Those patients with NASH with significant fibrosis presented an increase in the expression of mRNA TNF-alpha in comparison with those with a slight or nonexistent fibrosis. An overexpression of TNF-alpha mRNA is found in the liver and in the adipose tissue of NASH patients. The levels of mRNA-p55 are increased in the liver tissue of NASH patients. This overexpression is more elevated in patients with more advanced NASH. These findings suggest that the TNF-alpha system may be involved in the pathogenesis of NASH.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
October 2001, American journal of physiology. Cell physiology,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
February 1995, Blood,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
November 2000, Atherosclerosis,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
November 1997, The Journal of experimental medicine,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
November 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
March 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
June 2001, Journal of dental research,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
November 1992, Blood,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
December 2000, The Journal of infectious diseases,
J Crespo, and A Cayón, and P Fernández-Gil, and M Hernández-Guerra, and M Mayorga, and A Domínguez-Díez, and J C Fernández-Escalante, and F Pons-Romero
October 1992, Blood,
Copied contents to your clipboard!